Bloch; Paw
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bloch; Paw.The latest application filed is for "novel compounds for treatment of obesity".
- Bloch; Paw - Jyllinge DK
- Bloch; Paw - Taastrup DK
| Patent | Date |
|---|---|
| Novel Compounds For Treatment Of Obesity App 20210261641 - Roed; Nikolaj Kulahin ; et al. | 2021-08-26 |
| Double-acylated GLP-1 compounds Grant 10,689,429 - Linderoth , et al. | 2020-06-23 |
| GLP-1 derivatives Grant 10,308,700 - Lau , et al. | 2019-06-04 |
| GLP-1 derivatives Grant 9,758,560 - Lau , et al. September 12, 2 | 2017-09-12 |
| Semi-recombinant preparation of GLP-1 analogues Grant 9,732,137 - Lau , et al. August 15, 2 | 2017-08-15 |
| GLP-1 Derivatives App 20170145069 - Lau; Jesper ; et al. | 2017-05-25 |
| Double-Acylated GLP-1 Compounds App 20170114116 - Linderoth; Lars ; et al. | 2017-04-27 |
| Novel GLP-1 Derivatives App 20160108102 - Lau; Jesper ; et al. | 2016-04-21 |
| Aryl carbonyl derivatives as therapeutic agents Grant RE45,670 - Polisetti , et al. September 15, 2 | 2015-09-15 |
| GLP-1 Derivatives App 20140303083 - Lau; Jesper ; et al. | 2014-10-09 |
| Novel GLP-1 Derivatives App 20130244931 - Lau; Jesper ; et al. | 2013-09-19 |
| Acylated GLP-1 compounds Grant 8,536,122 - Lau , et al. September 17, 2 | 2013-09-17 |
| Novel Glp-1 Derivatives App 20130053315 - Lau; Jesper ; et al. | 2013-02-28 |
| Albumin-binding Conjugates Comprising Fatty-acid And Peg App 20130040884 - Lau; Jesper ; et al. | 2013-02-14 |
| Acylated GLP-1 Compounds App 20120295847 - Lau; Jesper ; et al. | 2012-11-22 |
| Acylated GLP-1 compounds Grant 8,129,343 - Lau , et al. March 6, 2 | 2012-03-06 |
| Aryl Carbonyl Derivatives As Therapeutic Agents App 20110301158 - Polisetti; Dharma Rao ; et al. | 2011-12-08 |
| Aryl carbonyl derivatives as therapeutic agents Grant 8,063,081 - Polisetti , et al. November 22, 2 | 2011-11-22 |
| Aryl carbonyl derivatives as therapeutic agents Grant 7,897,628 - Polisetti , et al. March 1, 2 | 2011-03-01 |
| Semi-recombinant Preparation Of Glp-1 Analogues App 20100317057 - Lau; Jesper Faergeman ; et al. | 2010-12-16 |
| Novel GLP-1 Derivatives App 20100305032 - Lau; Jesper ; et al. | 2010-12-02 |
| Synthesis and Application of New Structural Well Defined Branched Polymers as Conjugating Agents for Peptides App 20090240028 - Behrens; Carsten ; et al. | 2009-09-24 |
| Acylated GLP-1 Compounds App 20090156478 - Lau; Jesper ; et al. | 2009-06-18 |
| Aryl carbonyl derivatives as therapeutic agents Grant 7,541,373 - Polisetti , et al. June 2, 2 | 2009-06-02 |
| Aryl carbonyl derivatives as therapeutic agents Grant 7,384,967 - Polisetti , et al. June 10, 2 | 2008-06-10 |
| Aryl carbonyl derivatives as therapeutic agents App 20080119455 - Polisetti; Dharma Rao ; et al. | 2008-05-22 |
| Aryl carbonyl derivatives as therapeutic agents App 20080119454 - Polisetti; Dharma Rao ; et al. | 2008-05-22 |
| Novel Glp-1 Derivatives App 20070203058 - Lau; Jesper ; et al. | 2007-08-30 |
| Aryl carbonyl derivatives as therapeutic agents App 20060183783 - Polisetti; Dharma Rao ; et al. | 2006-08-17 |
| Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides App 20060182714 - Behrens; Carsten ; et al. | 2006-08-17 |
| Novel glucagon antagonists/inverse agonists App 20050256175 - Lau, Jesper ; et al. | 2005-11-17 |
| Glucagon antagonists/inverse agonists Grant 6,881,746 - Lau , et al. April 19, 2 | 2005-04-19 |
| Aryl carbonyl derivatives as therapeutic agents App 20040122235 - Polisetti, Dharma Rao ; et al. | 2004-06-24 |
| Novel glucagon antagonists/inverse agonists App 20040014789 - Lau, Jesper ; et al. | 2004-01-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 